Uncategorised - European Medical Journal

Evidence-Based Treatment of mCRPC

This satellite symposium at the European Society for Medical Oncology (ESMO) Congress 2025, chaired by Rana McKay, Professor of…

HIV Virologic Suppression Among Reincarcerated Individuals

The University of Illinois Hospital and Health Sciences Center (UIH), Chicago, USA, multidisciplinary telemedicine clinic provides HIV…

Tick, Tick, Boom! An Update on Tickborne Infections in the United States

The burden of tickborne diseases in the US more than doubled between 2004–2016, with >491,000 cases reported during this period…

Review of the European Society for Medical Oncology (ESMO) Congress 2025

THE EUROPEAN Society for Medical Oncology (ESMO) Congress 2025 took place in Berlin, Germany, a dynamic epicentre…

AMJ’s latest Microbiology and Infectious Diseases journal

Our new journal is out now – covering all the latest from IDWeek 2025. Inside, discover how long-acting PrEP options are transforming HIV…

IDWeek 2025: Key Discussions and Breakthroughs

ATLANTA, Georgia, USA, homebase for the CDC and a fitting stage for public health discourse, welcomed thousands of clinicians, scientists…

Established Therapies and Emerging Modalities in Lung Cancer

Over the past two decades, thoracic oncology has undergone a profound transformation, moving from limited chemotherapy regimens to…

The Evolving Biomarker Landscape in GI Cancers

First-Line Advances in TNBC: Datopotamab Deruxtecan and Sacituzumab Govitecan at ESMO 2025

THIS YEAR, the field of triple-negative breast cancer (TNBC) has witnessed significant advancements in the first line…

Virologic Failure Risk After Stopping Long-Acting CAB + RPV

Long-acting (LA) injectable cabotegravir-rilpivirine (CAB/RPV) is a novel antiretroviral therapy (ART) option for virologically suppressed…